InterventionsHuman trial225 participants72 weeksRandomised trial

Changes in Abdominal Adiposity and Associations With Metabolic Health Markers Following Tirzepatide in Japanese Participants With Obesity Disease: Results From the SURMOUNT-J Study

Graphical abstract from Endocrine Practice
Open the figure at full size
Graphical abstractWaki et al.

Endocrine Practice

The paper

Waki H, Kaneyuki E, Shingaki T et al.

Endocrine Practice · 19 Sep 2026

doi.org/10.1016/j.eprac.2026.09.006PubMed 42762980

More on GLP-1 and incretin signalling